Alibaba agrees to $600M DOJ settlement over illegal drug sales
Alibaba Group Holding Ltd. and AUS Merchant Services agreed to a $600 million non-prosecution agreement with the DOJ to resolve allegations of facilitating illegal pharmaceutical sales. The investigation revealed roughly 80,000 unlawful sales with a gross merchandise value exceeding $200 million between 2016 and 2024. Both companies admitted to compliance failures and agreed to financial penalties, while Alibaba also faces separate accusations regarding AI data harvesting.

*this image is generated using AI for illustrative purposes only.
Alibaba Group Holding Ltd. and U.S.-based payment processor AUS Merchant Services agreed to pay $600 million under a non-prosecution agreement to resolve allegations they failed to stop illegal pharmaceuticals and banned goods from reaching U.S. buyers through Alibaba’s online marketplaces. The settlement addresses claims that the companies' platforms facilitated transactions for items violating the Federal Food, Drug, and Cosmetic Act and other federal laws. This resolution concludes an investigation into compliance mechanisms, resolving claims without the companies admitting to the allegations.
According to the U.S. Department of Justice (DOJ), merchants using Alibaba.com and AliExpress carried out roughly 80,000 unlawful sales involving imports into the U.S. between January 2016 and December 2024. The sales included illegal pharmaceuticals, controlled substances, regulated chemicals, and pharmaceutical counterfeiting equipment, with a combined gross merchandise value exceeding $200 million. Federal investigators conducted more than 40 undercover purchases of illegal drugs and pill-making equipment during the probe.
Compliance Failures
The DOJ stated that Alibaba’s internal controls were not strong enough to prevent prohibited sellers from using its platforms. It also noted that some merchants used Alibaba’s private messaging tools and third-party encrypted apps to facilitate unlawful transactions. AUS, formerly known as Alipay U.S., admitted weaknesses in its anti-money-laundering compliance program. Court documents indicated the company failed to fully incorporate certain wire-transfer data into its transaction monitoring systems, causing it to miss some high-risk transactions. In at least one case, a merchant continued selling prohibited goods after being flagged.
Settlement Breakdown
The resolution involves a financial penalty and underscores the regulatory scrutiny on e-commerce platforms regarding product listings. The following table outlines the primary components of the agreement:
| Entity | Criminal Penalty | Forfeiture Amount |
|---|---|---|
| Alibaba Group | $125 million | $200 million |
| AUS Merchant Services | $85 million | $190 million |
Both companies agreed to strengthen compliance controls and continue cooperating with federal investigators. Assistant Attorney General Brett A. Shumate emphasized that companies operating online marketplaces must implement safeguards to stop bad actors from exploiting their platforms. Alibaba said it cooperated fully with the investigation and called the settlement a mutually satisfactory resolution.
Broader Scrutiny
The settlement comes as Alibaba faces broader scrutiny in the U.S. Last month, AI startup Anthropic accused the company of using thousands of fraudulent accounts to harvest nearly 28.8 million conversations from its Claude AI models. Alibaba did not publicly respond to that allegation. At the time of publication, Alibaba shares were down 1.58% at $96.44 in pre-market trading. The stock has traded between a 52-week high of $186.20 and a 52-week low of $88.65.
How will this settlement impact Alibaba's ability to attract and retain U.S. merchants on its platforms?
What specific technological upgrades will Alibaba and AUS implement to detect illicit transactions conducted via encrypted third-party apps?
Could this non-prosecution agreement set a legal precedent for increased regulatory scrutiny of other global e-commerce marketplaces?





























